NCT01612182View on ClinicalTrials.gov

The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

CompletedOBSERVATIONAL
Enrollment

1,289

Participants

Timeline

Start Date

March 31, 2012

Study Completion Date

May 31, 2012

Conditions
End-stage Renal Disease
Interventions
OTHER

renal replacement therapy

renal replacement therapy : hemodialysis and/or CRRT(continuous renal replacement therapy )

Trial Locations (1)

100-032

Inje University Seoul Paik hospital Instituional Board Review, Seoul

All Listed Sponsors
lead

Inje University

OTHER

NCT01612182 - The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy | Biotech Hunter | Biotech Hunter